Skip to main content
Home

Main dropdown menu

  • About us
    • About us
    • What we do
    • Who we are
      • ELIXIR Hub
      • ELIXIR Nodes
    • Why ELIXIR is needed
    • Governance
    • Data protection in ELIXIR
    • How we are funded
      • EU projects
      • Sustainability plan
    • ELIXIR publications
    • Impact
    • Job vacancies
  • What we offer
    • What we offer
    • Guidelines
    • Web portals
    • Services
    • Partnerships with industry and SMEs
    • Opportunities to work together
    • For ELIXIR members
  • How we work
    • How we work
    • ELIXIR Nodes
    • Scientific Programme
    • Platforms
      • Data
      • Tools
      • Compute
      • Interoperability
      • Training
    • Communities
      • 3D-BioInfo
      • Biodiversity
      • Cancer Data
      • Federated Human Data
      • Food and Nutrition
      • Galaxy
      • Human Copy Number Variation
      • Intrinsically Disordered Proteins
      • Metabolomics
      • Microbial Biotechnology
      • Microbiome
      • Plant Sciences
      • Proteomics
      • Rare Diseases
      • Research Data Management
      • Single-Cell Omics
      • Systems Biology
      • Toxicology
    • Focus Groups
      • AI Ecosystem
      • Communities Future
      • Domestic Animals Genome and Phenome
      • EOSC
      • Environmental Impact
      • Learning Paths
      • Pathogen Data
      • Professionalising Careers in Research Infrastructures
    • EU projects
    • Innovation and industry
    • Collaborations
  • Events
    • Events
    • ELIXIR All Hands
    • BioHackathon Europe
    • Bioinformatics Industry Forum
    • Innovation and SME Forums
  • News
  • Intranet

Breadcrumb

  1. Home

Czech Republic becomes fourth country to ratify ECA

  • Read more about Czech Republic becomes fourth country to ratify ECA

Autumn edition of newsletter now available

  • Read more about Autumn edition of newsletter now available

France latest country to join ELIXIR

  • Read more about France latest country to join ELIXIR

Switzerland ratifies ECA and invests €35 million

  • Read more about Switzerland ratifies ECA and invests €35 million

New building housing ELIXIR Hub officially opened

  • Read more about New building housing ELIXIR Hub officially opened

Summer edition of newsletter available

  • Read more about Summer edition of newsletter available

ELIXIR Consortium Agreement signed by Sweden

  • Read more about ELIXIR Consortium Agreement signed by Sweden

ELIXIR joins ETP4HPC

  • Read more about ELIXIR joins ETP4HPC

ELIXIR Consortium Agreement signed by the Biotechnology and Biological Sciences Research Council (BBSRC)

  • Read more about ELIXIR Consortium Agreement signed by the Biotechnology and Biological Sciences Research Council (BBSRC)

Help develop ELIXIR's industry strategy

  • Read more about Help develop ELIXIR's industry strategy

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 369
  • Page 370
  • Page 371
  • Page 372
  • Current page 373
  • Page 374
  • Page 375
  • Page 376
  • Page 377
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

ELIXIR Nodes

  • Belgium
  • Czech Republic
  • Denmark
  • EMBL-EBI
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Israel
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • UK
  • Cyprus (Observer)
  • Austria (Observer)
  • Romania (Observer)

Quick links

  • About us
  • Services
  • Platforms
  • Communities
  • Focus Groups
  • Innovation and Industry
  • Collaborations
  • Commissioned services
  • Get involved
  • Contact us
  • Data protection in ELIXIR
  • Vacancies
  • Glossary

ELIXIR logo

EU flag
ELIXIR is partly funded by the European Commission
within the Research Infrastructures programme of Horizon 2020.

The sole responsibility for the content of this webpage lies with ELIXIR.
It does not necessarily reflect the opinion of the European Union, and the European Commission is not responsible for any use that may be made of the information contained therein.

 ELIXIR-STEERS The ELIXIR-STEERS project receives funding from the European Union’s Horizon Europe Programme under grant agreement number 101131096

ELIXIR, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK
+44 (0)1223 492 670   info@elixir-europe.org

Copyright © 2025 | Privacy | Cookies